Integrating Exercise Into Lifestyle of Cardiac Outpatients
Efficacy of an Exercise-based Secondary Prevention Program in Patients With Stable Cardiovascular Disease
Università degli Studi di Ferrara
5,000 participants
Jan 1, 1997
OBSERVATIONAL
Conditions
Summary
The purpose of the study is to investigate the long-term effects of a personalized physical activity program on exercise capacity and quality of life in patients with stable cardiovascular disease. The analysis also intends to evaluate the prognostic value of cardiovascular function estimated through a walking test (1km Treadmill Walking Test, 1k-TWT) in relation to survival, hospitalization, and medical costs. The program considers clinical, socio-economic, and behavioural aspects, psychological support, and risk factor control. Patients receive indications for carrying out a home training program based on the performance of moderate-intensity aerobic activity at least 3-4 days a week for at least 30-60 minutes a day. All patients are also encouraged to improve their daily habits by preferring a more active lifestyle both at home and at work.
Eligibility
Inclusion Criteria1
- the presence of one or more previous cardiovascular events
Exclusion Criteria5
- Ejection fraction \< 30%
- Chronic heart failure NYHA III-IV
- Severe aortic or mitral valvulopathy
- Severe physical or cognitive impairment
- Exercise-induced complex arrhythmias
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
During each session, physical parameters are measured and data on medical history and physical activity are collected. To assess cardiorespiratory fitness, all patients complete a submaximal, moderate, and perceptually regulated treadmill walking test (1k-TWT). Patients unable to complete the test at a walking speed ≥ 3.0 km/h perform the test over 500m or 200m.
Patients receive recommendations for risk factor management as well as continuous motivational counselling in order to develop and maintain a stable active lifestyle.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05817305